BCR and chronic myelogenous leukemia, BCR-ABL1 positive: Overall, KW-2478 simultaneously inhibited the BCR/ABL and MAPK signalling pathways by disturbing the chaperone function of HSP90α and then induced obvious growth suppression in CML cells.